The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Ogorodnikov D.V.

The Centre of Reproduction and Genetics «Nova Clinic», Moscow, Russia, 119415

Ilyina I.Yu.

Department of Obstetrics and Gynecology, Faculty of General Medicine, N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia, Moscow, Russia

Dobrokhotova Iu.É.

Kafedra akusherstva i ginekologii Moskovskogo fakul'teta Rossiĭskogo gosudarstvennogo meditsinskogo universiteta

The effect of follicular high level progesterone on cycles of in vitro fertilization in protocols with antagonistsof gonadotropin-releasing hormone

Authors:

Ogorodnikov D.V., Ilyina I.Yu., Dobrokhotova Iu.É.

More about the authors

Journal: Russian Journal of Human Reproduction. 2019;25(2): 67‑77

Read: 2702 times


To cite this article:

Ogorodnikov DV, Ilyina IYu, Dobrokhotova IuÉ. The effect of follicular high level progesterone on cycles of in vitro fertilization in protocols with antagonistsof gonadotropin-releasing hormone. Russian Journal of Human Reproduction. 2019;25(2):67‑77. (In Russ.)
https://doi.org/10.17116/repro20192502167

Recommended articles:
Evaluation of prognostic factors of preterm birth. Russian Journal of Human Reproduction. 2025;(2):37-43
Vari­cose veins in chro­nic expe­riment. Piro­gov Russian Journal of Surgery. 2025;(7):16-23

References:

  1. Lin Y, Lan K, Huang F, Lin P, Chiang H, Kung F. Reproducibility and clinical significance of pre-ovulatory serum progesterone level and progesterone/estradiol ratio on the day of human chorionic gonadotropin administration in infertile women undergoing repeated in vitro fertilization cycles. Reproductive Biology and Endocrinology. 2015;13(1):41. https://doi.org/10.1186/s12958-015-0037-9
  2. Abuzeid M, Sasy M. Elevated progesterone levels in the late follicular phase do not predict success of in vitro fertilization-embryo transfer. Fertility and Sterility. 1996;65(5):981-985. https://doi.org/10.1016/s0015-0282(16)58273-9
  3. Kolibianakis EM, Venetis CA, Bontis J, Tarlatzis BC. Significantly Lower Pregnancy Rates in the Presence of Progesterone Elevation in Patients Treated with GnRH Antagonists and Gonadotrophins: a Systematic Review and Metaanalysis. Current Pharmaceutical Biotechnology. 2012;13(3):464-470. https://doi.org/10.2174/138920112799361927
  4. Al-Azemi M, Kyrou D, Kolibianakis E, Humaidan P, Van Vaerenbergh I, Devroey P, Fatemi H. Elevated progesterone during ovarian stimulation for IVF. Reproductive BioMedicine Online. 2012;24(4):381-388. https://doi.org/10.1016/j.rbmo.2012.01.010
  5. Al-Inany H, Aboulghar M, Mansour R, Serour G. Optimizing GnRH antagonist administration: metaanalysis of fixed versus flexible protocol. Reproductive BioMedicine Online. 2005;10(5):567-570. https://doi.org/10.1016/s1472-6483(10)61661-6
  6. Al-Inany H, Abou-Setta A, Aboulghar M. Gonadotrophin-releasing hormone antagonists for assisted conception: a Cochrane Review. Reproductive BioMedicine Online. 2007;14(5):640-649. https://doi.org/10.1016/s1472-6483(10)61059-0
  7. Bosch E, Valencia I, Escudero E, Crespo J, Simón C, Remohí J, Pellicer A. Premature luteinization during gonadotropin-releasing hormone antagonist cycles and its relationship with in vitro fertilization outcome. Fertility and Sterility. 2003;80(6):1444-1449. https://doi.org/10.1016/j.fertnstert.2003.07.002
  8. Bosch E, Labarta E, Crespo J, Simón C, Remohí J, Jenkins J, Pellicer A. Circulating progesterone levels and ongoing pregnancy rates in controlled ovarian stimulation cycles for in vitro fertilization: analysis of over 4000 cycles. Human Reproduction. 2010;25(8):2092-2100. https://doi.org/10.1093/humrep/deq125
  9. Griesinger G, Mannaerts B, Andersen CY, Witjes H, Kolibianakis EM, Gordon K. Progesterone elevation does not compromise pregnancy rates in high responders: a pooled analysis of in vitro fertilization patients treated with recombinant follicle-stimulating hormone/gonadotropin-releasing hormone antagonist in six trials. Fertility and Sterility. 2013;100(6):1622-1628.e3. https://doi.org/10.1016/j.fertnstert.2013.08.045
  10. Chabbert-Buffeta N. Neuroendocrine effects of progesterone. Steroids. 2000;65(10-11):613-620. https://doi.org/10.1016/s0039-128x(00)00187-2
  11. De Geyter C. Progesterone serum levels during the follicular phase of the menstrual cycle originate from the crosstalk between the ovaries and the adrenal cortex. Human Reproduction. 2002;17(4):933-939. https://doi.org/10.1093/humrep/17.4.933
  12. Micevych P, Sinchak K. Synthesis and Function of Hypothalamic Neuroprogesterone in Reproduction. Endocrinology. 2008;149(6):2739-2742. https://doi.org/10.1210/en.2008-2011
  13. Werner M, Forman E, Hong K, Franasiak J, Molinaro T, Scott R. Defining the «sweet spot» for administered luteinizing hormone-to-follicle-stimulating hormone gonadotropin ratios during ovarian stimulation to protect against a clinically significant late follicular increase in progesterone: an analysis of 10,280 first in vitro fertilization cycles. Fertility and Sterility. 2014;102(5):1312-1317. https://doi.org/10.1016/j.fertnstert.2014.07.766
  14. Cai Q, Wan F, Appleby D, Hu L, Zhang H. Quality of embryos transferred and progesterone levels are the most important predictors of live birth after fresh embryo transfer: a retrospective cohort study. Journal of Assisted Reproduction and Genetics. 2013;31(2):185-194. https://doi.org/10.1007/s10815-013-0129-4
  15. Venetis C, Kolibianakis E, Bosdou J, Tarlatzis B. Progesterone elevation and probability of pregnancy after IVF: a systematic review and meta-analysis of over 60 000 cycles. Human Reproduction Update. 2013;19(5):433-457. https://doi.org/10.1093/humupd/dmt014
  16. Casarini L, Lispi M, Longobardi S, Milosa F, La Marca A, Tagliasacchi D, Pignatti E, Simoni M. LH and hCG Action on the Same Receptor Results in Quantitatively and Qualitatively Different Intracellular Signalling. PLoS One. 2012;7(10):e46682. https://doi.org/10.1371/journal.pone.0046682
  17. Sonigo C, Dray G, Roche C, Cédrin-Durnerin I, Hugues J. Impact of high serum progesterone during the late follicular phase on IVF outcome. Reproductive BioMedicine Online. 2014;29(2):177-186. https://doi.org/10.1016/j.rbmo.2014.03.027
  18. Lindeberg M, Carlström K, Ritvos O, Hovatta O. Gonadotrophin stimulation of non-luteinized granulosa cells increases steroid production and the expression of enzymes involved in estrogen and progesterone synthesis. Human Reproduction. 2006;22(2):401-406. https://doi.org/10.1093/humrep/del408
  19. Hugues J. Impact of ‘LH activity’ supplementation on serum progesterone levels during controlled ovarian stimulation: a systematic review. Human Reproduction. 2011;27(1):232-243. https://doi.org/10.1093/humrep/der380
  20. Thuesen L, Smitz J, Loft A, Nyboe Andersen A. Endocrine effects of hCG supplementation to recombinant FSH throughout controlled ovarian stimulation for IVF: a dose-response study. Clinical Endocrinology. 2013;79(5):708-715. https://doi.org/10.1111/cen.12186
  21. Devroey P, Pellicer A, Nyboe Andersen A, Arce J. A randomized assessor-blind trial comparing highly purified hMG and recombinant FSH in a GnRH antagonist cycle with compulsory single-blastocyst transfer. Fertility and Sterility. 2012;97(3):561-571. https://doi.org/10.1016/j.fertnstert.2011.12.016
  22. Fleming R, Jenkins J. The source and implications of progesterone rise during the follicular phase of assisted reproduction cycles. Reproductive BioMedicine Online. 2010;21(4):446-449. https://doi.org/10.1016/j.rbmo.2010.05.018
  23. Kyrou D, Kolibianakis E, Fatemi H, Tarlatzis B, Tournaye H, Devroey P. Is earlier administration of human chorionic gonadotropin (hCG) associated with the probability of pregnancy in cycles stimulated with recombinant follicle-stimulating hormone and gonadotropin-releasing hormone (GnRH) antagonists? A prospective randomized trial. Fertility and Sterility. 2011;96(5):1112-1115. https://doi.org/10.1016/j.fertnstert.2011.08.029
  24. Santi D, Casarini L, Alviggi C, Simoni M. Efficacy of Follicle-Stimulating Hormone (FSH) Alone, FSH + Luteinizing Hormone, Human Menopausal Gonadotropin or FSH + Human Chorionic Gonadotropin on Assisted Reproductive Technology Outcomes in the «Personalized» Medicine Era: A Metaanalysis. Frontiers in Endocrinology. 2017;8:114. https://doi.org/10.3389/fendo.2017.00114
  25. Mochtar M, Danhof N, Ayeleke R, Van der Veen F, van Wely M. Recombinant luteinizing hormone (rLH) and recombinant follicle stimulating hormone (rFSH) for ovarian stimulation in IVF/ICSI cycles. Cochrane Database of Systematic Reviews. 2017;5:CD005070. https://doi.org/10.1002/14651858.cd005070.pub3

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.